SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
176 hedge funds and large institutions have $278M invested in Sage Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 58 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 58
26% less capital invested
Capital invested by funds: $374M → $278M (-$95.5M)
Holders
176
Holding in Top 10
1
Calls
$2.74M
Puts
$1.1M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$16.6M | |
| 3 | +$7.54M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.47M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.34M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$8.98M | |
| 3 | -$7.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.01M |